{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:55:27Z","timestamp":1790924127156,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["TEC2017-85059-C3-2-R"],"award-info":[{"award-number":["TEC2017-85059-C3-2-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.colsurfb.2019.06.018","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T13:47:50Z","timestamp":1560260870000},"page":"657-670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Nanostructured supramolecular hydrogels: Towards the topical treatment of Psoriasis and other skin diseases"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-5531","authenticated-orcid":false,"given":"David","family":"Lim\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirian","family":"Tall\u00f3 Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Gardu\u00f1o-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4989-4821","authenticated-orcid":false,"given":"Ana C.","family":"Calpena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2031-4405","authenticated-orcid":false,"given":"Llu\u00efsa","family":"P\u00e9rez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2019.06.018_bib0005","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3949\/ccjm.79a.11133","article-title":"Psoriasis: evolving treatment for a complex disease","volume":"79","author":"Villase\u00f1or-Park","year":"2012","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0020","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1242\/dmm.009092","article-title":"Putting together the psoriasis puzzle: an update on developing targeted therapies","volume":"5","author":"Johnson-Huang","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","article-title":"Psoriasis","volume":"7","author":"Perera","year":"2012","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The immunogenetics of Psoriasis: a comprehensive review","volume":"64","author":"Harden","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.01488","article-title":"CLA+T cell response to microbes in psoriasis","volume":"9","author":"De Jes\u00fas-Gil","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.autrev.2006.12.002","article-title":"Biologic therapies in psoriasis: a new therapeutic approach","volume":"6","author":"Gisondi","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0045","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2165\/00003495-200969090-00001","article-title":"Ustekinumab: a new option in psoriasis therapy","volume":"69","author":"Chien","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s40257-016-0179-3","article-title":"Novel oral therapies for psoriasis and psoriatic arthritis","volume":"17","author":"Yiu","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0055","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1345\/aph.10261","article-title":"Tacrolimus in dermatologic disorders","volume":"35","author":"Skaehill","year":"2001","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0060","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/j.1365-2133.2004.06017.x","article-title":"Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis","volume":"150","author":"Kyll\u00f6nen","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0065","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaad.2008.11.906","article-title":"Methotrexate and psoriasis: 2009 national psoriasis foundation consensus conference","volume":"60","author":"Kalb","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0070","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1365-2133.2003.05667.x","article-title":"Dramatic improvement of psoriasis with gemcitabine monotherapy","volume":"149","author":"Landi","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0075","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1046\/j.1365-2133.2000.03915.x","article-title":"Resolution of psoriatic skin lesions after chemotherapy with gemcitabine and vinorelbine","volume":"143","author":"Genvresse","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0080","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1039\/C0CC03293J","article-title":"Supramolecular gel chemistry: developments over the last decade","volume":"47","author":"Steed","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1039\/C3SM52244J","article-title":"Insights into low molecular mass organic gelators: a focus on drug delivery and tissue engineering applications","volume":"10","author":"Skilling","year":"2014","journal-title":"Soft Matter"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0090","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1016\/j.biomaterials.2007.07.044","article-title":"Hydrogel biomaterials: a smart future?","volume":"28","author":"Kope\u010dek","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0095","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1039\/b417081b","article-title":"Supramolecular gels: functions and uses","volume":"34","author":"Sangeetha","year":"2005","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clae.2011.12.005","article-title":"Protein deposition on contact lenses: the past, the present, and the future","volume":"35","author":"Luensmann","year":"2012","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0105","doi-asserted-by":"crossref","first-page":"8412","DOI":"10.1039\/C4TB01375A","article-title":"Gelation properties of self-assembling N-acyl modified cytidine derivatives","volume":"2","author":"Skilling","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0110","doi-asserted-by":"crossref","first-page":"9494","DOI":"10.1021\/acs.joc.6b01853","article-title":"Inhibition of C(2)-H activity on alkylated imidazolium monocations and dications upon inclusion by cucurbit[7]uril","volume":"81","author":"Li","year":"2016","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0115","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejpb.2015.09.007","article-title":"Novel nanostructured supramolecular hydrogels for the topical delivery of anionic drugs","volume":"96","author":"Lim\u00f3n","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0120","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1039\/C4TB00450G","article-title":"Supramolecular gels based on a gemini imidazolium amphiphile as molecular material for drug delivery","volume":"2","author":"Rodrigues","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0125","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1039\/C6CC09392B","article-title":"Microscale coiling in bis-imidazolium supramolecular hydrogel fibres induced by release of a cationic serine protease inhibitor","volume":"53","author":"Lim\u00f3n","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0130","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/open.201700040","article-title":"Cationic supramolecular hydrogels for overcoming the skin barrier in drug delivery","volume":"6","author":"Lim\u00f3n","year":"2017","journal-title":"ChemistryOpen"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0135","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1021\/la203601n","article-title":"Gemini imidazolium amphiphiles for the synthesis, stabilization, and drug delivery from gold nanoparticles","volume":"28","author":"Casal-Dujat","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jps.22271","article-title":"Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen","volume":"100","author":"Gonz\u00e1lez-Mira","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejpb.2015.01.026","article-title":"Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration","volume":"95","author":"Abrego","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0150","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jps.2600561005","article-title":"Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms","volume":"56","author":"Gibaldi","year":"1967","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0155","series-title":"Basic Criteria for the in Vitro Assessment of Dermal Absorption of Cosmetic Ingredients, Eur. Comm. SCCS\/1358","first-page":"1","author":"Scientific Committee on Consumer Safety","year":"2010"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0160","series-title":"Guidelines for the Testing of Chemicals, Section 4, Test No. 428: Skin Absorption: In Vitro Method","author":"OECD","year":"2004"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0165","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1021\/cm021792u","article-title":"Structural studies of a new low molecular mass organic gelator for organic liquids based on simple salt","volume":"15","author":"Ballabh","year":"2003","journal-title":"Chem. Mater."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0170","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1365-4632.2006.02911.x","article-title":"The treatment of psoriasis vulgaris: 1% topical methotrexate gel","volume":"45","author":"Eskicirak","year":"2006","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0175","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archderm.1989.01670140079014","article-title":"Topical methotrexate therapy for psoriasis","volume":"125","author":"Weinstein","year":"1989","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0180","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3109\/10837450.2015.1026605","article-title":"A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation","volume":"21","author":"Avasatthi","year":"2016","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0185","series-title":"Rheology","first-page":"59","article-title":"Polymer Gel Rheology and Adhesion","author":"Grillet","year":"2012"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0190","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/pi.4980180103","article-title":"Fundamentals of hydrogels and gelation","volume":"18","author":"Ross-Murphy","year":"1986","journal-title":"Br. Polym. J."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0195","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.trac.2012.02.007","article-title":"Quantitative 1H NMR spectroscopy","volume":"35","author":"Bharti","year":"2012","journal-title":"TrAC - Trends Anal. Chem."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0200","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1021\/bm060264z","article-title":"Encapsulation of drug reservoirs in fibers by emulsion electrospinning: Morphology characterization and preliminary release assessment","volume":"7","author":"Qi","year":"2006","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0205","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0168-3659(02)00041-X","article-title":"Release of tetracycline hydrochloride from electrospun poly (ethylene-co-vinylacetate), poly (lactic acid), and a blend","volume":"81","author":"Kenawy","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0210","first-page":"67","article-title":"Electrospun nanofiber-based drug delivery systems","volume":"1","author":"Yu","year":"2009","journal-title":"Health (Irvine. Calif.)"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0215","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0168-3659(03)00342-0","article-title":"Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer","volume":"92","author":"Verreck","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0220","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1039\/b507157g","article-title":"Two-stage enzyme mediated drug release from LMWG hydrogels","volume":"3","author":"van Bommel","year":"2005","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0225","doi-asserted-by":"crossref","first-page":"16141","DOI":"10.1021\/la1029905","article-title":"Supramolecular chirality in organogels: A detailed spectroscopic, morphological, and rheological investigation of gels (and Xerogels) derived from alkyl pyrenyl urethanes","volume":"26","author":"Das","year":"2010","journal-title":"Langmuir"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0230","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/1521-3757(20010202)113:3<633::AID-ANGE633>3.0.CO;2-R","article-title":"Chiral recognition in bis-urea-Based aggregates and organogels through cooperative interactions","volume":"113","author":"de Loos","year":"2001","journal-title":"Angew. Chem."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0235","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1039\/b800409a","article-title":"Lost in translation? Chirality effects in the self-assembly of nanostructured gel-phase materials","volume":"38","author":"Smith","year":"2009","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0240","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1039\/C3NJ01295F","article-title":"Using gel morphology to control pore shape","volume":"38","author":"Foster","year":"2014","journal-title":"New J. Chem."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0245","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.cherd.2012.08.014","article-title":"Controlled drug release via minimization of burst release in pH-response kappa-carrageenan\/polyvinyl alcohol hydrogels","volume":"91","author":"Hezaveh","year":"2016","journal-title":"Chem. Eng. Res. Des."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0250","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0168-3659(01)00360-1","article-title":"Controlled release of clot-dissolving tissue-type plasminogen activator from a poly(l-glutamic acid) semi-interpenetrating polymer network hydrogel","volume":"75","author":"Park","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0255","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-5173(02)00433-7","article-title":"Minimization of initial burst in poly(vinyl alcohol) hydrogels by surface extraction and surface-preferential crosslinking","volume":"248","author":"Huang","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0260","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(01)00248-6","article-title":"On the importance and mechanisms of burst release in matrix-controlled drug delivery systems","volume":"73","author":"Huang","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0265","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijpharm.2010.11.029","article-title":"Dermal targeting of tacrolimus using colloidal carrier systems","volume":"404","author":"Goebel","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0270","series-title":"Mild to Moderate Psoriasis","author":"Koo","year":"2014"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0275","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","article-title":"The 500 Dalton rule for the skin penetration of chemical compounds and drugs","volume":"9","author":"Bos","year":"2000","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0280","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1002\/jps.21277","article-title":"Proteins and peptides: strategies for delivery to and across the skin","volume":"97","author":"Benson","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0285","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0378-5173(94)90390-5","article-title":"Analysis of percutaneous permeation data: II. Evaluation of the lag time method","volume":"109","author":"Shah","year":"1994","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0290","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00280-006-0339-x","article-title":"Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphoma","volume":"59","author":"Gerber","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0295","series-title":"Tissue Eng.","first-page":"359","article-title":"In vivo and in vitro models of Psoriasis","author":"Jean","year":"2010"},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0300","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1523-1747.1999.00538.x","article-title":"Animal models of psoriasis - What can we learn from them?","volume":"112","author":"Schon","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0305","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/17460441.2011.632629","article-title":"Psoriasis drug discovery: methods for evaluation of potential drug candidates","volume":"7","author":"Svensson","year":"2012","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12895-016-0046-1","article-title":"Effect of 12-O-tetradecanoylphorbol-13-acetate-induced psoriasis-like skin lesions on systemic inflammation and atherosclerosis in hypercholesterolaemic apolipoprotein E deficient mice","volume":"16","author":"Madsen","year":"2016","journal-title":"BMC Dermatol."},{"key":"10.1016\/j.colsurfb.2019.06.018_bib0315","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.2147\/IJN.S170832","article-title":"Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles","volume":"13","author":"Sun","year":"2018","journal-title":"Int. J. Nanomedicine"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776519304229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776519304229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:40:49Z","timestamp":1790923249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776519304229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":63,"alternative-id":["S0927776519304229"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2019.06.018","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanostructured supramolecular hydrogels: Towards the topical treatment of Psoriasis and other skin diseases","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2019.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}